Skip to main content
OpenTrials

Clinical trial condition

KRAS-mutant Non-small Cell Lung Cancer (NSCLC)

Explore clinical trials studying KRAS-mutant Non-small Cell Lung Cancer (NSCLC). Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study
Refine in advanced search Browse all conditions

KRAS-mutant Non-small Cell Lung Cancer (NSCLC) trial results

Recruiting

A Phase 1 Dose-escalation Trial of KST-6051 in Participants With Advanced Solid Tumors With Kirsten Rat Sarcoma Viral Oncogene Homolog (KRAS) Mutation

NCT07458347

Conditions
Adenocarcinoma, Biliary Tract Diseases, Biliary Tract Neoplasms, +44 more
Locations
  • Cedars-Sinai Medical Center Los Angeles, California, United States
  • Florida Cancer Specialists Sarasota, Florida, United States
  • Moffitt Cancer Center Tampa, Florida, United States
  • Mass General Brigham Cancer Institute at Massachusetts General Hospital Boston, Massachusetts, United States
View Trial Details

Related conditions